Planting the seeds of human health. PLANTING THE SEEDS OF HUMAN HEALTH. First in the world to offer the clinically-tested lifespan and healthspan enhancing Osmotin plant protein product line. Available now in the US and worldwide. Visit 9dbio.com for more info. biotech, cell life and death cycle, plant biotechnology, human health, age-reversing, and agriculture

182 similar entities Type: Startup Activities: biotech deeptech agritech Technologies: Synthetic Biology

Biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. SpliceBio is a biotechnology company exploiting Protein Splicing to develop the next generation of gene therapies. Our proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein and protein engineering research by our co-founders. The company is backed by UCB Ventures, Ysios Capital, NEA, Gilde Healthcare, Novartis Venture Fund and Asabys Partners.

86 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We incubate, fund, and launch new companies that use programmed biology to shape the human future. Ferment is a venture studio building new companies that rapidly translate biology into products that solve targeted problems across industrial and consumer markets including food & nutrition, industrials & waste, materials, consumer health and more. synbio, synthetic biology, biotech, programmed biology, venture studio, company creation studio, incubator, venture capital, biotechnology, industrial biotechnology, and consumer biotechnology

73 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Transforming protein biologics with groundbreaking high-throughput protein engineering. Avenue Biosciences is a biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of production barriers. Headquartered in San Francisco, USA, and with laboratory operations in Helsinki, Finland, Avenue Biosciences has developed a protein engineering platform that combines organic biology and machine learning to boost protein production. The proprietary method is based on years of scientific research from the University of Helsinki, Finland. Our goal is to drive significant progress in biotechnology by providing turnkey solutions that streamline production, improve quality, …

103 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

‘Off-the-Shelf’ Curative Cell Therapies About Us: Cell BioEngines is a US-based clinical-stage biotechnology company developing off-the-shelf allogeneic cell therapies by chemically reprogramming stem cell fate and function to treat serious and currently incurable diseases. Leveraging cord blood stem cells from highly compatible 'super-donors' and powered by its proprietary STEM-Space cellular reprogramming platform, the company delivers scalable cell products with reduced risk of immune rejection. Cell BioEngines’ competitive edge comes from a unique combination of a transgene-free scalable manufacturing platform enabled by advanced chemical reprogramming, rigorous HLA-guided design, and a population-informed biobank that supports broad patient coverage. Cell BioEngines lead clinical …

311 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A Ferring Company working to harness the power of the human microbiome to address unmet medical needs. Rebiotix Inc, part of the Ferring Pharmaceuticals Group, is a clinical-stage biotechnology company revolutionizing the treatment of challenging gastrointestinal diseases by harnessing the power of the human microbiome. Our highly skilled and dynamic team is based out of Roseville, Minnesota. Please feel free to contact us through our website at www.rebiotix.com. Biotechnology, Microbiome, Drug Development, Medicine, Clinical Trials, Regulatory Innovation, Patient Support, Internal Medicine, Manufacturing, Infectious Disease, Gastroenterology, Emerging Diseases, and Novel Technology

113 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Precision Gut Health. Zero Lab Friction. Most microbiome companies are struggling with shipping poop kits. We skipped the lab entirely. Our software, BiomePulse, uses a proprietary algorithm to predict biomarkers instantly from clinical data. microbiome, biotics, GenerativeAI, Nutrition, Pharma, and Healthcare

88 similar entities Type: Startup Activities: healthtech Technologies: A.I.

Clinically proven probiotics for the benefit of human health throughout life. Products available B2C & B2B worldwide. BioGaia is a Swedish probiotic company that has been at the forefront of microbiome research for more than 35 years. BioGaia develops, manufactures, markets, and sells probiotic products within the areas of gut health, oral health, and immune health. Our probiotic products with bacterial strains from the L. reuteri species are among the most scientifically well-documented probiotics. BioGaia`s products are distributed through own subsidiaries or distribution partners in more than 100 countries.The class B share of BioGaia is quoted on the Mid Cap …

44 similar entities Type: SMB Activities: healthtech deeptech

Nature's pharmacy, re-engineered Biomia is a synthetic biology company developing a pipeline of plant-inspired natural or new-to-nature therapeutic products to address the unmet medical needs in pain, addiction, and mental health conditions.

84 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Late clinical stage company focused on drug discovery and development for the treatments of rare disorders of the CNS For additional information: info@sombiotech.com Pre-clinical validation, Licensing, In silico screening, Rare Diseases, Drug repurposing, Orphan CNS indications, Central Nervous System, Intellectual Property, and Artificial Intelligence

288 similar entities Type: Startup Activities: biotech deeptech legaltech Technologies: A.I. Synthetic Biology

CONNECT COLLABORATE EVOLVE Biotrains is a global leader in providing business conferences, training, managed events, and consulting services tailored to the Pharmaceutical, Biotech, Healthcare, and Medical Device industries. We specialize in delivering world-class content and expert knowledge to empower professionals and give organizations a competitive edge. Our events cover technical areas such as Bioprocess Development, Drug Discovery, Diagnostics, Personalized Medicine, Medical Devices, and Healthcare. With a focus on innovation and continuous learning, Biotrains is dedicated to fostering success in both business and academia. Event , Conference, Trainnig, Pharmaceutical, Biotechnology, Home Healthcare, Pharma IT, drugformulation, and workshops

112 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing a biobased future is our passion. Industrial biotechnology is our business. The BRAIN Biotech Group is a leading company in the research, development and production of specialist enzymes with a focus on the food and life science industries. In addition, the Group develops microbial production organisms and scalable bioprocesses for the economic production of specialty enzymes and other proteins. Customized innovative biological solutions for more sustainable products and processes round off the portfolio. BRAIN Biotech AG is the parent company of the BRAIN Biotech Group. The business activities of the integrated company are divided into the two segments BRAINBiocatalysts …

104 similar entities Type: SMB Activities: healthtech biotech civictech deeptech Technologies: Batteries Bio sourced materials Synthetic Biology

Plants, a source of innovation. VitroRun is an innovative company whose objective is to produce vitroplants (pejibaye, vanilla plants, etc.) and to provide support to agricultural sectors in securing their supplies of healthy materials. Our know-how also allows us to carry out actions to preserve Reunion's heritage, and thus ensure the continued existence of certain species. Expertise driven by a passionate team ready to make plants a new area of ​​innovation. Our main missions: - Production of healthy plants for farmers - Offer of R&D services - Innovation in the field of plants For more information: contact@vitrorun.re In vitro plant …

97 similar entities Type: Startup Activities: agritech deeptech Technologies: New Materials

Design, Production, and Delivery of Antibodies – Reimagined by AI Genotic utilizes AI for the rapid design and production of customized antibodies for all kinds of targets. Our fully computational, animal-free approach guarantees high quality and delivers solutions within weeks, not years. biotechnology, machine learning, and antibody

247 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: A.I.

High-Capacity Gene Therapy Vector Platform to Address Prevalent Diseases Now part of Pacira Biosciences. GQ Bio is pioneering a high-capacity gene therapy vector platform (HCAd) that addresses some of the big challenges in the gene therapy field: Transfer of large and multiple genes with a single vector, highly efficient gene delivery (high transduction efficiency), and large-scale manufacturability. Based on its HCAd vector platform, GQ Bio develops transformative treatments for chronic, prevalent conditions such as osteoarthritis and intervertebral disc degeneration. GQ Bio is headquartered in Hamburg, Germany and has sites at Luckenwalde (greater Berlin area), Germany and Liège, Belgium. biotechnology, gene …

70 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Leading biotech in the development of innovative microbiome-based biotherapies YSOPIA Bioscience is a clinical-stage biotech company developing cutting-edge biotherapies based on the gut microbiome. Our goal is to bring safe & efficient solutions to patients with high unmet medical needs. Microbiome, Obesity, Gut modulator, Cardiometabolism, Cardiometabolic diseases, Microbiota, and Gut microbiota

298 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Igyxos develop more effective/efficient infertility treatment for patients Igyxos is a biotechnology company based out of CENTRE INRAe VAL DE LOIRE SITE DE TOURS, NOUZILLY, France. Biotechnologie, Fertilité, and anticorps monoclonal

180 similar entities Type: SMB Activities: biotech healthtech Technologies: Synthetic Biology

Bringing People & Ressources Together The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of patients in the field of rheumatology, dermatology and aesthetic. We believe that tomorrow medicine needs to be dedicated and targeted to patients. We aim to improve existing treatments by using non invasive processes allowing local and sustained administration of biological and active molécules. The company, incepted in 1998, has currently a staff of 11 people and is located in Sophia Antipolis (South of France). For …

633 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Pioneering biomimicry in Europe. Together with your R&D teams, we engineer breakthrough bio-inspired technologies. Boost your innovation thanks to nature's best designs. Biomimétisme, Ingénierie, Deeptech, Mécanique, Thermique, Chimie, Optique, Conception, IA, Design, and Matériaux

97 similar entities Type: Startup Activities: cleantech greentech manufacturing biotech deeptech Technologies: Decarbonization

We build foundation models that will transform biology. We use cutting-edge technology to transform multiscale data into actionable representations to fuel breakthrough discoveries. Join us on our mission to build foundation models that transform biology. artificial intelligence, biology, and foundation models

104 similar entities Type: Startup Activities: biotech it services Technologies: Generative A.I. A.I.

Sustainable microbiota-based solutions Aviwell operates at the convergence of DIGITAL & LIFE SCIENCES. Our mission is to develop natural and sustainable solutions to improve animal health to better nourish and provide FOOD SECURITY to the nearly 8 billion people on our planet ... And to do so a fraction of the cost. We are a deep-tech startup with our HQ in Toulouse, France and with sales offices in Boston, USA. The company is based on three disruptive assets: • Proprietary biostatistical algorithms, • Extensive microbiology and physiology expertise, and • Native and Adaptive Biomimicry When combined, we are able to …

130 similar entities Type: SMB Activities: biotech deeptech Technologies: A.I.

Improving Metabolic Health Through Microbiome Science Genbioma is a biotechnology company that transforms microbiome science into clinically validated postbiotics that enhance cardiometabolic health by restoring microbiota balance, naturally activating metabolism and the GLP‐1 pathway Health, microbiome, probiotics, postbiotics, diabetes, Microbiota, obesity, cholesterol, prediabetes, GLP-1, and insulin resistance

89 similar entities Type: Startup Activities: deeptech Technologies: SaaS

Glox Therapeutics Ltd. is developing novel precision antibiotics based on protein bacteriocins, which have potent narrow-spectrum activity to target Gram-negative Antimicrobial Resistant (AMR) pathogens.

160 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Accelerate Biotechnology Batavia Biosciences is a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies. We are not your standard CDMO - our customers regularly refer to us as their product development partner and thought partner. We focus on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization to clinical manufacturing. Headquartered in Leiden, The Netherlands, Batavia Biosciences is privileged to have strong strategic partners in …

132 similar entities Type: Startup Activities: deeptech Technologies: Synthetic Biology

Gradiant Bioconvergence (GBCC) is Korea's first organoid-focused company. We built the country's largest patient-derived organoid biobank, spanning nearly 1,000 models across lung, gastric, colorectal, pancreatic, ovarian, and breast cancer, with accompanying NGS data. Our scientific advisory board includes Dr. Toshiro Sato, a co-inventor of the foundational organoid technology and a former lab member of Dr. Hans Clevers, and Dr. Byoung Chul Cho, a professor of medical oncology at Yonsei University College of Medicine and chief of the Lung Cancer Center at Yonsei Cancer Center.

78 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Playing music to cells Kolibri revolutionises the way we grow and engineer cells at scale using acoustic waves. 🔍 Book a discovery call: https://calendly.com/tamsin_kolibrilab/discovery-call Showing 10x increase in cell density and 50x reduction in production costs, our patented bioreactors help our partners in drug development unlock patient access to gene therapies, with a proof of principle in AAV gene therapy. Being cell-agnostic and scalable, our process has significant potential across a range of high-value cell-based therapies - or in the cellular agriculture space more broadly. gene therapy, biomanufacturing, cellculture, acoustics, hardtech, and biotech

385 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Frontier models for all molecules of life. We are making biology programmable to transform health and sustainability for the benefit of all. We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizing existing enzymes, and advancing genetic engineering. Contact us to work with us today.

134 similar entities Type: Startup Activities: biotech healthtech deeptech Technologies: A.I. Generative A.I.

Neocor is dedicated to pioneering transformative therapies in cardiac care We are currently developing a novel gene therapy approach targeting ischemic and rare genetic cardiac diseases, and moving from lab preclinical trials to regulatory trials. The Company was founded in October and has received strong traction since inception. We will be looking to strengthen our human and financial ressources in the coming month in order to start the regulatory pre clinical trials. gene therapy, biotechnology, rare disease, and cardiology

337 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Amicus Therapeutics is now part of BioMarin Pharmaceutical Inc., a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. For more information on BioMarin, please visit https://www.biomarin.com/ and follow @BioMarin Pharmaceutical Inc. on LinkedIn for updates.

109 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

We were made for this 53Biologics is a end-to-end biologics CDMO built to keep progress moving. By combining scientific expertise, integrated in-house capabilities and a collaborative way of working, we enable confident decision-making as biologics programs evolve. We support your biologic from early development to commercialization. With USP and DSP development, GMP manufacturing, quality control and fill-finish connected under one roof, we reduce handoffs, protect continuity and help clients grow without disruption. We were made for this. Biopharmaceuticals , CDMO, pDNA, Recombinant Protein, GMP, Drug Development, Microbial Manufacturing, Cell Banking, and GMP Manufacturing

353 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Innovation & Mycology | Empowering The Fungi World Innomy develops global solutions for the food industry such as meat analogues or functional flours, always using sustainable biotechnological processes based on fungal mycelia and revaluing by-products from various industries as raw materials. Mycelium, Nutrition, Food Tech, Wet Protein, Functional Flours, Meat Analogues, Fungi , Biotech, Healthy Food, Umami, Sustainable, Science, Natural Products, Protein, Food Industry, By-products, Functional Food, Super Food, Fungi Based Meat, Fungi Meat, Fungi Food, and Mushroom Meat

96 similar entities Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or follow us at @agenus_bio. Our Community Guidelines are available at our website and at: https://agenusbio.com/community-guidelines/ Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors and Modulators, Immunotherapy, Cell therapy, Antibodies, and GMP Manufacturing

171 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. We offer autonomous laboratories that replace manual laboratory work with robotics in the lab, greatly improving the productivity of scientists. Ginkgo's in-house autonomous lab is also available as a "cloud lab" through our Datapoints and Solutions contract research services. cultured ingredients, biological engineering, metabolic engineering, gmos, synthetic biology, programming cells, automation, digital technology, and AI for Biology

75 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology SaaS

Transforming Labs with AI and Automation Reshape Biotech is building the next generation of lab automation robots. Our customers are biotech companies tackling the world’s biggest problems - be it alternative protein development or sustainable agriculture. Reshape Biotech is the scaling factor for these companies, as we let researchers collaborate globally on experiments and increase their throughput >500x. The team is highly multi-disciplinary, employing everything from PhD’s in biology to hardware and software engineers. We work closely together, and you will be exposed to a truly vertical team. We’re a fast growing startup with an incredibly ambitious team, dead-set on …

135 similar entities Type: Startup Activities: deeptech biotech Technologies: Robotics

Orchestrating gut health® EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome.

143 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

a wholly owned subsidiary of Eli Lilly and Company LimmaTech Biologics AG, a wholly owned subsidiary of Eli Lilly and Company, is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. vaccines, research & development, biotechnology, and antimicrobial resistance

419 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

We’re using ground-breaking cell technologies to revolutionise global food production - starting with pork Uncommon Bio began with cell-based meat and pioneered RNA delivery innovations, which evolved into their most recent spin out which is focusing on changing medicine through multi-targeting. Their polysaccharide-based delivery platform enables multi-pathway cell programming, offering a safe, efficient and scalable alternative to multi-target therapies. The company is initially targeting severe lung diseases like idiopathic pulmonary fibrosis and is backed by industry leaders from BioNTech and top investors, including Sam Altman, Balderton, Lowercarbon, and Redalpine. science+art, biotech, mRNA, IPF, Pulmonary fibrosis, and delivery

561 similar entities Type: Startup Activities: biotech deeptech foodtech Technologies: Synthetic Biology

Driving Bio-Industry Growth as Michigan's only state-wide life-sciences association. The Advocate for Michigan's bio-industry! MichBio is a non-profit association representing more than 600 bioscience companies, universities and academic institutions dedicated to advancing Michigan's bioscience industry. MichBio is the state's leading advocate for the bio-industry. MichBio fosters an environment that educates the public and policy makers, influences public policy and advances the economic interests of its member companies and the industry as a whole. Creating Value, Building Networks, Impacting Policy, and Growing Talent

53 similar entities Type: SMB Activities: biotech deeptech

A biotech startup redefining our most basic understanding of the ageing process Based at the Babraham Research Campus in Cambridge, LinkGevity is a pioneering drug discovery company founded on ground-breaking research in longevity science. Our goal is to change the paradigm of ageing, paving the way for people to live healthier lives for longer. Contact us on info@linkgevity.com

129 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Helping health & biotech companies, researchers and entrepreneurs making their projects and dreams come true. GENESIS Biomed is a consultancy firm in the biomedical healthcare sector specialized in providing consulting services in the genesis and first phases of lifecycle of biomedical spin-off and start-up companies, entrepreneurs and research centers. Based in our expertise we help entrepreneurs and researchers to shape their business plan and we support them in the private fundraising process. We have raised 68,5 M€ in the last years in 20 rounds. We are Associate Partner at EIT Health and we are engaged to 23 EU projects with …

254 similar entities Type: SMB Activities: deeptech healthtech consulting entrepreneurship fintech biotech Technologies: A.I.

Meat is evolving. We’re growing the next generation of it with mycelium—no animals involved, same delicious taste. We are an early-stage biotech company on a mission to unlock the potential of fermentation to revolutionise the animal protein industry. Our team is united by a shared passion for our mission, combining scientific and business skills to create a fast-paced and collaborative culture! We are backed by some of Europe’s leading FoodTech and ClimateTech VC investors and are based in Berlin and Leipzig.

177 similar entities Type: Startup Activities: foodtech biotech Technologies: Decarbonization

Global Leaders in Mammalian Cell Line Development KBI Biopharma and Selexis SA are consolidating operations as one organization under the KBI Biopharma name. This streamlined approach supports customers in accelerating drug development and manufacturing, creating greater flexibility, efficiencies, and a simplified partner experience. You can follow us on the KBI Biopharma page to stay up-to-date on the latest news, events, and happenings. Cell Line Development, HTS, Cell Line Engineering, Contract Biological Services, Stable Cell Line Development, Cell Engineering, Variant Screening, Research Cell Banks, Monoclonal Antibodies, Whole Genome Sequencing, Bispecific Antibodies, CDMO, Monoclonality Assessment, Biotechnology, Biosimilars, Cell line engineering, Genetic engineering, …

589 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Technology development, R&D, Biobased ingredients Activatec develops technologies to produce biobased ingredients from renewable sources. We are specialised in the evaluation, scale-up and commercialisation of processes to produce biotechnological and plant-based ingredients and materials from currently unused and low-value organic sources. Activatec is a B2B Partner that provides support to the industrial biotechnology sector in the form of research services on a contract basis. We are currently working within a number of international partner projects to design, develop and scale-up novel technologies for the production of emerging and high-value bio-based products. biotechnology, research and development, biotech, biobased products, bioproducts, bioingredients, …

133 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Bio sourced materials

Crafting the future of oils & fats, starting with cocoa butter. Guided by Nature, shaped by innovation. Oils and fats are the backbone of modern industry. They touch everything, from food to pharma to cosmetics. At Abydos Bioscience, we’re reimagining a new way produce these essential ingredients with a process that’s sustainable, scalable and highly efficient. We’ve built a biotechnology platform that trains bacteria to produce oil and fat alternatives that mirror the chemical composition and functionality of those found in nature. Guided by nature, shaped by innovation. *No trees or animals are harmed in the making of our product* …

158 similar entities Type: Startup Activities: deeptech Technologies: SaaS

Pioneering Precision Biocontrols Biotalys is an Agricultural Technology (AgTech) company developing precision biocontrol solutions based on proteins for the protection of crops in both the pre- and post-harvest markets. The company provides novel solutions that bridge the efficacy and scale of chemistry with the environmental advantages of biological solutions. Based on its novel AGROBODYTM technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from …

257 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Develop human organ models with true physiological complexity We are specialized in the production and development of human, immunocompetent Organ-on-Chip technology for in vitro disease and infection modelling. Organ-on-Chip, Human Cell Biology, Infection, Infectious disease, Toxicity profiling, Immune Cell Interactions, Inflammatory Diseases, Antibody recycling, and Uptake / Transport studies

263 similar entities Type: Startup Activities: manufacturing biotech deeptech Technologies: Synthetic Biology

Empresa de base biotecnológica basada en IA, metabolómica y genómica para el diagnóstico de embriones preimplantatorios. A biotechnology company that develops noninvasive diagnostic services for preimplantation embryos based on AI, metabolomics, embryo images, and clinical data for human-assisted reproduction treatments.

Type: Startup Activities: deeptech biotech Technologies: A.I. Data Analytics

Transforming translational medicine with 3D microtissue screening to accelerate human-relevant drug discovery Hooke Bio Ltd. was founded in 2014 by Professor Mark Davies at Stokes Laboratories, University of Limerick (UL), a research center which has a rich history of microfluidic entrepreneurship. Hooke Bio spun out from UL in 2017 and has been based in Shannon, Co. Clare, Ireland since 2019. To date, Hooke Bio have been awarded up to 12M in investment from a combination of private, angel and public funds. A portion of this has come from the prestigious European Innovation Council (EIC) Accelerator funding of which Hooke was …

58 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Ventures at the crossroad of Health and Technology CRB is a Private Venture Capital Management firm specialized in Health Technologies. It was founded by a senior multi-disciplinary executive team. It has incorporated three previous Funds with focus on Biotech (Fund I), Medtech (Fund II), and Digital Health (Fund Nuubo). Currently incorporating the Fund III (CRB Digital Health III), a specialized Fund on Digital Health supported by a team with a large experience in startups, scaleups, corporates, and public health institutions. Based in Madrid and Barcelona, with access to the most innovative hubs in Europe. comunicacion@crossroadbiotech.com Lactose intolerance, Alzheimer, Wearable technologies, …

137 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I.

Ikena merged with ImageneBio on in July 2025. Please visit https://inmagenebio.com/ for more information. Ikena merged with ImageneBio in July 2025. Please visit https://inmagenebio.com/ for more information. Targeted Oncology, cancer therapeutics development, small molecule drug design, cancer biology, and translational science and biomarkers

81 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

The ingredient for your success! In the heart of Ariège, GENIBIO develops and produces your food and cosmetic ingredients. With almost 30 years of existence, GENIBIO supports you thanks to its expertise in the fields of plant extraction and pre- and probiotics. GENIBIO masters the essential technologies for the production of total or selective plant extracts: selection of raw materials, grinding, hydroalcoholic extraction, enzymatic extraction, micro-, ultra and nanofiltration, membrane concentration, stabilization of concentrated liquid extracts, drying by spray drying or lyophilization. GENIBIO is also an expert in mixing probiotic strains, with associated analytical techniques (viability, flow cytometry, aging studies, …

19 similar entities Type: SMB Activities: deeptech

The Swiss knife longevity discovery partner. At Nagi Bioscience, we deliver the world’s first automated in vivo solution to simultaneously measure lifespan, healthspan, and biological age in a single, streamlined workflow. We are the partner of choice for biotech, nutraceutical, and pharmaceutical companies developing the future of aging and longevity interventions. Trusted globally, we combine Swiss-engineered precision with over 15 years of expertise in aging biology, supporting leading innovators in bringing life-changing interventions to society, faster. Microfluidic technology, Drug Screening, Pre-clinical studies, Lab Automation Technology, Safety and Efficacy, Toxicology, AI, C. elegans, 3Rs, Biomedical Research, Neurodegeneration studies, Aging research, and …

102 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Better Access. Better Lives. Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars. Biopharmaceuticals, Research and Development, Biosimilars, Biotechnology, Pharmaceutical, Biogenerics, Health, Cell Line Development, Business Development, and Regulatory

418 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Ensure sustainability and produce more with less. We believe that making the world a better place is possible by uniting talented people with innovative companies. Thus, we have developed a complete and unique experience in the biological market, capable of providing equipment, inputs and technical assistance in an integrated manner so that rural producers can produce their own bio-inputs on the farm with quality, profitability and agronomic efficiency. Bioinputs, OnFarm Biological Management, Biotechnology, and OnFarm Bioinputs

244 similar entities Type: Startup Activities: deeptech Technologies: Bio sourced materials

Developing novel IVD solutions Genz is a spin-off biotech company developing novel solutions from in vitro diagnostics to therapeutics. Our mission is to deliver a consistent stream of innovative, affordable, and accessible diagnostic solutions and make a remarkable impact on people’s lives. We’re focused on sustainable growth and addressing the world’s pressing health challenges; therefore, we’re able to create value for both our patients and our shareholders. To date, Genz developed 4 IVD diagnostic tests commercially legalized, attended International joint projects, partnered with top research centers in the world and published several scientific articles in international scientific journals. Biotechnology, Genetik …

315 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Worldwide Biotech Company Database BioPharmGuy is a website that functions as a directory of companies in the biotechnology, pharmaceutical, medical device & life science industries. We offer services for businesses as well as job seekers. The site is constantly being updated to ensure we have the most accurate and high quality, free-to-use database.

84 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Avoid diets, eat better! DietSensor is an innovative nutrition coaching app for weight loss and healthy eating. It was crowned Best of Innovation at CES in Las Vegas in 2016. Our startup is based in France and in the US. We are open to partnerships. Don’t hesitate to contact our founder Rémy BONNASSE Visit our website to learn more www.dietsensor.com Healthcare, Diet Tracking, Wellness, Internet of Things, Diabetes , and Nutrition

215 similar entities Type: Startup Activities: healthtech biotech deeptech Technologies: IoT

Professional hygiene itself. OUR CORE BUSINESS: BIOTECHNOLOGY APPLIED TO THE ENVIRONMENT. Since 1988, in collaboration with world-renowned research centers such as the #cnrs, HTS BIO has imagined, designed and manufactured in France ecological, high-performance and cutting-edge products and solutions for #hygiene, #cleaning, bioremediation (biological depollution), agriculture, aquaculture, water treatment and bodies of water. They are developed using exclusive microbiological processes and meet the highest economic and environmental requirements. AUGMENTED BIOTECHNOLOGY Do you have innovative projects? Do you want to propel innovative technology in terms of distribution and responsible consumption? Augmented biotechnology is the alliance of your ideas with our #biotech …

102 similar entities Type: SMB Activities: deeptech water management

Empowering AI and Mechanistic Knowledge (hybrid models) to speed up bioprocess development and model predictive control. Novasign is a young company focused to bring advanced machine learning tools to biotech to ultimately speed up bioprocess development therefore reducing time to market of both new molecules as well as biosimilars. The company is a spin-off from the University of Natural Resources and Life Science Vienna currently based in Vienna in close proximity to the Vienna Institute of Biotechnology biotechnology, hybrid modeling, modeling, bioprocess, upstream, downstream, consulting, CHO, chromatography, and TFF

68 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning

Oak Hill Bio's mission is to develop life-changing medicines for patients suffering from rare diseases Oak Hill Bio is a clinical-stage biotech company committed to developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Our mission: Drive farm profitability through improved feed performance while contributing to a food-secure future. We are Knip (formally KnipBio), a women-led biotechnology company based in Boston, pioneering advanced nutritional solutions for animal feeds. Using a naturally occurring microbe, our precision feed ingredients are sustainably produced without reliance on arable land and minimal water use. aquaculture, agriculture, synthetic Biology, fermentation, and blue economy

100 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Grounded in nature, authored by AI Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Emeryville, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures. To learn more about our mission to decode the language of life with AI, visit profluent.bio. artificial intelligence, machine learning, biotech, and gene editing

88 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology A.I. - Machine Learning Generative A.I.

Mango Materials develops methane-to-PHA biomanufacturing technology for industrial partnerships and licensing. YOPP® products and commercial applications --> MadeWithYOPP.com bioplastics, methane, and biomanufacturing

124 similar entities Type: Startup Activities: biotech deeptech Technologies: New Materials